BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK. CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Brown RE. Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress? The EuroBiotech Journal 2022;6:61-88. [DOI: 10.2478/ebtj-2022-0008] [Reference Citation Analysis]
2 Bhattacharjee G, Gohil N, Khambhati K, Mani I, Maurya R, Karapurkar JK, Gohil J, Chu DT, Vu-Thi H, Alzahrani KJ, Show PL, Rawal RM, Ramakrishna S, Singh V. Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications. J Control Release 2022:S0168-3659(22)00080-3. [PMID: 35149141 DOI: 10.1016/j.jconrel.2022.02.005] [Reference Citation Analysis]
3 Vigneswaran J, Muthukumar SA, Shafras M, Pant G. An insight into Alzheimer’s disease and its on-setting novel genes. Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00420-2] [Reference Citation Analysis]
4 Bhatia S, Makkar R, Behl T, Sehgal A, Singh S, Rachamalla M, Mani V, Iqbal MS, Bungau SG. Biotechnological Innovations from Ocean: Transpiring Role of Marine Drugs in Management of Chronic Disorders. Molecules 2022;27:1539. [DOI: 10.3390/molecules27051539] [Reference Citation Analysis]